Stockreport

Eli Lilly Launches Foundayo: A Novel Oral GLP-1 Weight Management Therapy [TheStreet.com]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Following FDA approval on April 1, 2026, the company designed this once-daily oral medication to treat adults managing obesity or overweight conditions accompanied by we [Read more]